日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Resonance-free Fabry-Pérot cavity via unrestricted orbital-angular-momentum ladder-up

通过不受限制的轨道角动量阶跃上升实现无共振法布里-珀罗腔

Yaraghi, Shaghayegh; Mhibik, Oussama; Yessenov, Murat; Miller, J Keith; Parto, Midya; Johnson, Eric G; Abouraddy, Ayman F; Divliansky, Ivan

Observation of Boyer-Wolf Gaussian modes

对博耶-沃尔夫高斯模式的观测

Tschernig, Konrad; Guacaneme, David; Mhibik, Oussama; Divliansky, Ivan; Bandres, Miguel A

NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts

NRX-0492 可降解野生型和 C481 突变型 BTK,并在 CLL 患者来源的异种移植模型中显示出体内活性。

Deyi Zhang ,Hailey M Harris ,Jonathan Chen ,Jen Judy ,Gabriella James ,Aileen Kelly ,Joel McIntosh ,Austin Tenn-McClellan ,Eileen Ambing ,Ying Siow Tan ,Hao Lu ,Stefan Gajewski ,Matthew C Clifton ,Stephanie Yung ,Daniel W Robbins ,Mehdi Pirooznia ,Sigrid S Skånland ,Erika Gaglione ,Maissa Mhibik ,Chingiz Underbayev ,Inhye E Ahn ,Clare Sun ,Sarah E M Herman ,Mark Noviski ,Adrian Wiestner

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

CD49d表达可识别出一种生物学上独特的慢性淋巴细胞白血病亚型,该亚型在接受BTK抑制剂治疗后无进展生存期较差。

Alsadhan, Anfal; Chen, Jonathan; Gaglione, Erika M; Underbayev, Chingiz; Tuma, Pamela L; Tian, Xin; Freeman, Lita A; Baskar, Sivasubramanian; Nierman, Pia; Soto, Susan; Itsara, Andy; Ahn, Inhye E; Sun, Clare; Bibikova, Elena; Hartmann, Tanja Nicole; Mhibik, Maissa; Wiestner, Adrian

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

CD3×CD20双特异性抗体epcoritamab在慢性淋巴细胞白血病(CLL)中的细胞毒性可通过同时靶向BTK或BCL-2而增强。

Mhibik, Maissa; Gaglione, Erika M; Eik, David; Herrick, John; Le, Janet; Ahn, Inhye E; Chiu, Christopher; Wielgos-Bonvallet, Monica; Hiemstra, Ida H; Breij, Esther C W; Chen, Jenny; Reilly, Edward B; Epling-Burnette, Pearlie K; Szafer-Glusman, Edith; Sun, Clare; Wiestner, Adrian

Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression

免疫调节恶性 B 细胞促进慢性淋巴细胞白血病进展

Arsène Mékinian, Anne Quinquenel #, Koceïla Ait Belkacem #, Feriel Kanoun, Elisabetta Dondi, Emilie Franck, Marouane Boubaya, Maïssa Mhibik, Fanny Baran-Marszak, Rémi Letestu, Florence Ajchenbaum-Cymbalista, Vincent Lévy, Nadine Varin-Blank, Christine Le Roy

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

针对 T 细胞募集的患者来源的 Siglec-6 靶向抗体对慢性淋巴细胞白血病具有潜在的治疗作用

Matthew G Cyr, Maissa Mhibik, Junpeng Qi, Haiyong Peng, Jing Chang, Erika M Gaglione, David Eik, John Herrick, Thomas Venables, Scott J Novick, Valentine V Courouble, Patrick R Griffin, Adrian Wiestner, Christoph Rader

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL

BTK 抑制剂(无论 ITK 抑制与否)可增强 CD19/CD3 双特异性抗体在 CLL 中的疗效

Maissa Mhibik, Erika M Gaglione, David Eik, Ellen K Kendall, Amy Blackburn, Keyvan Keyvanfar, Maria Joao Baptista, Inhye E Ahn, Clare Sun, Junpeng Qi, Christoph Rader, Adrian Wiestner

Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report

严重肾性范可尼综合征及其在关节挛缩-肾功能障碍-胆汁淤积综合征中的治疗策略:病例报告

Rosales, Alejandra; Mhibik, Maissa; Gissen, Paul; Segarra, Oscar; Redecillas, Susana; Ariceta, Gema

Scleroderma Peripheral B Lymphocytes Secrete Interleukin-6 and Transforming Growth Factor β and Activate Fibroblasts

硬皮病外周B淋巴细胞分泌白细胞介素-6和转化生长因子β并激活成纤维细胞

Nicolas Dumoitier, Benjamin Chaigne, Alexis Régent, Sébastien Lofek, Maissa Mhibik, Peter Dorfmüller, Benjamin Terrier, Jonathan London, Alice Bérezné, Nicolas Tamas, Nadine Varin-Blank, Luc Mouthon